Is Trastuzumab Deruxtecan Effective in ERBB2-Mutant NSCLC?

Trastuzumab deruxtecan monotherapy shows systemic as well as intracranial effectiveness in patients with previously treated ERBB2-mutant NSCLC.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/trastuzumab-deruxtecan-effective-erbb2-mutant-nsclc-2025a1000vv4?src=rss

Author :

Publish date : 2025-11-17 09:30:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Is Trastuzumab Deruxtecan Effective in ERBB2-Mutant NSCLC?

No Time to Die: Is Well-Being the Elixir for Healthy Aging?

Measles and Hand-Foot-Mouth Disease Rates Climbing

Related Posts

Dozens of Illness Reports Linked to Infant Formula Recalls

PAHO Issues Alert as Measles Cases Surge Across the Americas

Fellow Nurses: Was Alexis Lawler Treated Fairly?

$2M Gender Care Med-Mal Verdict; Botched Blepharoplasty Case; Ob/Gyn’s Abortion Suit

Fast-charging quantum battery built inside a quantum computer

Just One in Eight Nurses Would Recommend the Profession

Dozens of Illness Reports Linked to Infant Formula Recalls

PAHO Issues Alert as Measles Cases Surge Across the Americas

Fellow Nurses: Was Alexis Lawler Treated Fairly?

$2M Gender Care Med-Mal Verdict; Botched Blepharoplasty Case; Ob/Gyn’s Abortion Suit

Fast-charging quantum battery built inside a quantum computer

Just One in Eight Nurses Would Recommend the Profession

Study Adds Fuel to the Debate Over Cataract Surgery and Wet AMD

Catherine O’Hara’s Rare Condition: Here’s What to Know

Categories

Archives